Key Takeaways

• Amazon is pivoting its ad platform around third‑party agents, turning them into the primary salesforce for 2026 and beyond.
• Google’s seasonal‑adjustment test signals a race to give advertisers more granular control, intensifying competition in the ad‑tech ecosystem.
• Pharma advertising spend is soaring, with Bimzelx leading Q3 drug‑ad investments, highlighting how niche verticals are shaping ad strategies.
• Advertisers must adapt: embracing agent‑centric models, leveraging AI‑driven tools, and preparing for a fragmented, data‑rich marketplace.

---

Amazon Ads unBoxed 2026: The New Agent‑Centric Playbook

The Amazon Ads unBoxed 2026 conference, held in Bengaluru this March, sent shockwaves through India’s digital marketing community. The headline announcement—Amazon Positions Its Ad Business Around Agents—marks a decisive shift from a platform‑first approach to an agent‑first ecosystem.

What Happened?

• Strategic realignment: Amazon’s ad leadership unveiled a roadmap that places registered advertising agents at the core of campaign creation, optimization, and reporting.
• Revenue‑share model: Agents will earn a tiered commission based on spend, with higher rebates for performance‑driven outcomes.
• Toolkits & APIs: A new suite of APIs, sandbox environments, and a dedicated Agent Dashboard were launched, enabling agencies to automate bulk buying, access first‑party shopper data, and run cross‑device attribution.
• Geographic focus: While the global rollout is slated for Q4 2026, India receives priority due to its rapid e‑commerce growth and a thriving agency landscape.

Why It’s Trending on Google Trends

The query “ad” spiked to over 100 k searches on Google Trends India within days of the event, reflecting two intertwined forces:

1. Curiosity about Amazon’s new model – advertisers, brand managers, and media buyers are scrambling to understand how the agent‑centric model will affect media planning budgets.
2. Fear of disruption – traditional DSPs and programmatic platforms fear losing market share to Amazon’s deep shopper insights and now, its empowered network of agents.

Industry analysts predict that Amazon’s move could re‑channel up to 15 % of India’s digital ad spend toward its ecosystem by 2028, a figure that rivals Google’s dominance.

advertising agents collaborating

---

The Competitive Landscape: Google Ads Tests Seasonal Adjustments

While Amazon is building an agent‑first framework, Google Ads quietly rolled out a test for ad‑group‑level seasonal adjustments for App campaigns, as reported by Search Engine Land. This feature lets advertisers tweak bids based on upcoming holidays, festivals, or product launch windows directly at the ad‑group tier.

How Google Is Responding

• Granular control: Advertisers can now set a +15 % bid boost for the Diwali season on specific app categories, without affecting the broader campaign.
• AI‑driven predictions: Google leverages historical performance data to suggest optimal seasonal percentages, aiming to reduce manual guesswork.
• Beta rollout: The test is limited to India and a handful of APAC markets, but early adopters report a 12 % lift in ROAS during peak periods.

This move underscores Google’s strategy to double‑down on precision as Amazon expands its reach. Both giants are essentially fighting for the same advertiser dollars, but through different levers—Amazon via agents, Google via AI‑enhanced platform tools.

---

Pharma Advertising: A Parallel Shift in Spend

The ad‑tech upheaval isn’t confined to e‑commerce. Fierce Pharma highlighted that UCB’s Bimzelx topped Q3 drug‑ad spend, prompting the question: who will claim the annual prize? The pharmaceutical sector is increasingly treating ad spend as a strategic asset, especially in a market where digital prescriptions and tele‑health are exploding.

Key Observations

1. Vertical specialization: Pharma agencies are building proprietary data pipelines to comply with stringent regulations while still delivering personalized ads.
2. Platform diversification: Brands are splitting budgets across Amazon, Google, and niche health‑focused networks to mitigate risk.
3. Performance metrics: Click‑through rates (CTR) for pharma ads on Amazon have risen 8 % YoY, driven by Amazon’s shopper intent data.

The convergence of Amazon’s agent model and Google’s seasonal tools presents pharma marketers with new decision points: whether to partner with an Amazon‑approved agent for shopper‑centric campaigns or to leverage Google’s predictive seasonal adjustments for app‑based health solutions.

---

Implications for Advertisers and Agencies

Opportunities

• Access to first‑party data: Amazon agents will gain unprecedented visibility into purchase pathways, enabling hyper‑targeted creative.
• Higher ROI through specialization: Agencies that certify as Amazon agents can command premium fees, backed by performance‑based rebates.
• Seasonal agility: Google’s new feature empowers brands to react swiftly to market dynamics without overhauling entire campaigns.

Challenges

• Learning curve: Agencies must invest in training to master Amazon’s new dashboard, APIs, and compliance requirements.
• Data silos: Balancing data from Amazon, Google, and pharma‑specific platforms will demand robust data‑management frameworks.
• Regulatory scrutiny: Especially for pharma ads, ensuring that agent‑mediated campaigns comply with the Drugs and Cosmetics Act will be critical.

Strategic Recommendations

1. Hybrid agency model: Combine Amazon‑agent capabilities with Google’s AI tools to create a dual‑platform playbook.
2. Invest in MarTech: Deploy a unified data‑layer (e.g., CDP) to harmonize insights across platforms.
3. Pilot seasonal adjustments: Test Google’s seasonal bid boosts on a small budget before scaling, to gauge incremental lift.
4. Compliance first: For pharma, partner with agencies that have proven regulatory audit trails.

---

Editorial Analysis & Future Outlook

Amazon’s decision to anchor its ad business around agents is more than a tactical shift; it signals a structural transformation of the Indian digital advertising ecosystem. By delegating the front‑line sales and activation to specialized partners, Amazon can scale its ad inventory faster, while agents gain a lucrative revenue stream tied to performance.

In the next 12‑24 months, we expect:

• Rapid certification programs as agencies scramble to become Amazon‑approved partners.
• Increased competition for talent: Data scientists and performance marketers will be in high demand to navigate the new agent dashboards.
• Consolidation: Smaller agencies may merge or form consortia to meet Amazon’s minimum spend thresholds.
• Cross‑platform orchestration: Brands will increasingly run synchronized campaigns—Amazon‑agent‑driven shopper ads paired with Google’s seasonal bid adjustments—to capture both purchase intent and timely relevance.
• Regulatory evolution: As pharma and other regulated verticals adopt these models, India’s advertising standards board may introduce new guidelines for agent‑mediated digital spend.

Ultimately, the ad‑tech battlefield is moving from a platform‑centric duel to a multi‑layered choreography of agents, AI, and vertical expertise. Advertisers who adopt a flexible, data‑first mindset—leveraging Amazon’s agent network for shopper‑centric reach while exploiting Google’s granular seasonal tools for timing precision—will be best positioned to dominate the evolving landscape.

The story is still unfolding, but one thing is clear: 2026 will be the year the ad agency renaissance begins, powered by Amazon’s agent model and amplified by Google’s AI‑driven refinements.

---

Original Reporting & Source: Google Trends (India)